
San Diego’s Halozyme laying off 160 after dropping experimental cancer drug
San Diego biotech will focus on its profitable drug injection technology […]
San Diego biotech will focus on its profitable drug injection technology […]
Dauntless Pharmaceuticals formed in 2016, and its founders said the Sofinnova Ventures-backed firm planned to take a new approach to building biotechs. Instead of advancing a broad stable of early-stage drug candidates under the same roof, Dauntless ai… […]
LA JOLLA?The Salk Institute announced today that it received more than $89 million from 1,204 individual donors and private grant makers in fiscal year 2019 (ending in June) to support the Institute?s world-renowned science. The amount is the most rais… […]
An experimental Halozyme Therapeutics treatment for pancreatic cancer has failed a pivotal study, and the company is stopping further development of the drug and closing its oncology operations as part of a corporate restructuring. Halozyme (NASDAQ: HA… […]
SAN DIEGO–(BUSINESS WIRE)–ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) today announced the appointment of Ponni Subbiah, M.D., M.P.H., as Senior Vice President, Global Head of Medical Affairs and Chief Medical Officer. Dr. Subbiah will report to Serge … […]
Halozyme, a San Diego-based biotech, said that its lead drug, for pancreatic cancer, had failed to extend the lives of patients in a clinical trial. […]
Experience leading groups in a pharmaceutical or biotechnology setting. Vertex Pharmaceuticals Incorporated is seeking an exceptional scientific leader to drive…From Vertex – Mon, 04 Nov 2019 11:18:06 GMT – View all San Diego, CA jobs […]
Scientists say obstacles to HIV prevention with a vaccine are yielding to research […]
Up to 88 percent fewer new drug approvals projected in study commissioned by Biocom and California Life Sciences Association. […]
Copyright © 2021 | MH Magazine WordPress Theme by MH Themes